Callos Andrew Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$3.75M

Insider Activity of Callos Andrew

According to the SEC Form 4 filings, Callos Andrew, being in a position of

  1. EVP, Chief Commercial Officer at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 236948 shares for $16.02M,
    over all time since 2025-03-03, has bought 0 shares, and sold 331171 share for $20.05M.

Biography of Callos Andrew

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $16,021,29422100

Comparison of Insiders on Amount of Buys and Sells

2026-08-31SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
10,000
0.0075%
$70.24$702,400-8.81%
2026-07-30SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
14,000
0.0112%
$79.88$1.12M-13.81%
2026-07-01SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
15,000
0.0121%
$85.80$1.29M-13.65%
2026-06-01SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
15,000
0.0116%
$74.08$1.11M+0.02%
2026-05-05SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
11,333
0.0108%
$77.25$875,474-2.7%
2026-05-01SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
15,857
0.0132%
$65.00$1.03M+18.41%
2026-04-30SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
15,000
0.0129%
$63.26$948,900+16.99%
2026-04-15SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
7,449
0.0062%
$66.02$491,783+13.25%
2026-03-31SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
3,639
0.0029%
$65.00$236,535+10.89%
2026-03-18SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
1,930
0.0016%
$62.07$119,795+15.66%
2026-03-17SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
8,542
0.0069%
$62.15$530,885+15.41%
2026-03-16SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
1,709
0.0014%
$61.03$104,300+17.51%
2026-03-09SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
2,582
0.0021%
$60.72$156,779+13.98%
2026-03-05SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
26,000
0.0212%
$61.87$1.61M+14.02%
2026-03-02SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
886
0.0007%
$61.62$54,595+15.11%
2026-02-05SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
15,000
0.0126%
$61.93$928,950+13.63%
2026-02-02SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
886
0.0007%
$62.10$55,021+4.51%
2026-01-05SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
15,000
0.0124%
$60.28$904,200+8.91%
2026-01-02SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
1,798
0.0015%
$62.62$112,585+8.08%
2025-12-29SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
1,809
0.0015%
$62.44$112,954+7.89%
Total: 32
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.